Caps on Medicare prescription drug costs will save Part D enrollees a collective $7.4 billion in 2025, according to a report from HHS' Office of the Assistant Secretary for Planning and Evaluation.
Author: Rylee Wilson
Medicare will provide broader coverage of Leqembi, a drug that has been shown to slow the progression of Alzheimer's disease, now that the drug has received full FDA approval.
The most common reason health plans and employers do not pay for pricey weight loss drugs is because they consider these medications to be lifestyle drugs, according to a survey from Pharmaceutical Strategies Group.
Georgia is implementing work requirements for Medicaid, and other states could follow.
Molina Healthcare had the largest gains in Medicaid enrollment during the COVID-19 pandemic, according to a report from KFF published July 6.
"Look-alike" dual eligible Medicare Advantage plans — which primarily enroll people eligible for Medicare and Medicaid but are not regulated as D-SNP plans — grew significantly from 2013 to 2020, a study published in the July issue of Health Affairs…
Many Medicare Advantage plans have narrow networks for psychiatrists when compared to Medicaid managed care and ACA plans, a study published in the July issue of Health Affairs found.
Eli Lilly is now the largest healthcare company in the world by market value, surpassing UnitedHealth Group, Bloomberg reported July 5.
Squabbles over the state's budget could delay implementation of Medicaid expansion in North Carolina.
Prime Therapeutics has promoted Mostafa Kamal to be the pharmacy benefit manager's next CEO.
